Michael Yurkowsky
Chief Executive Officer at INNOVEREN SCIENTIFIC INC.
Net worth: 306 $ as of 2024-03-30
Profile
Michael W.
Yurkowsky is the founder of Deverra Therapeutics, Inc. He currently holds multiple positions.
He is the Chief Executive Officer & Independent Director at Innoveren Scientific, Inc. since 2021.
He is also the Chief Executive Officer at Immuni-T, Inc., the Owner of YP Holdings LLC (Florida), and the President of Jantibody LLC.
In the past, he served as the Director at Vicapsys Life Sciences, Inc. from 2019 to 2022.
He was also a Vice President-Investments at Wachovia Securities LLC from 1997 to 2003.
Additionally, he was the Owner of Trenchant Asset Management Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INNOVEREN SCIENTIFIC INC
1.30% | 2023-05-09 | 9,261 ( 1.30% ) | 306 $ | 2024-03-30 |
Michael Yurkowsky active positions
| Companies | Position | Start |
|---|---|---|
| INNOVEREN SCIENTIFIC INC. | Chief Executive Officer | 2021-12-05 |
| YP Holdings LLC (Florida) | Corporate Officer/Principal | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Chief Executive Officer | - |
| Immuni-T, Inc. | Chief Executive Officer | - |
Jantibody LLC
 Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a private company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | President | - |
Former positions of Michael Yurkowsky
| Companies | Position | End |
|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Director/Board Member | 2022-09-21 |
Wachovia Securities LLC
 Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Corporate Officer/Principal | 2003-07-31 |
| Trenchant Asset Management Ltd. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Health Technology |
| INNOVEREN SCIENTIFIC INC. | Health Technology |
| Private companies | 6 |
|---|---|
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
| Trenchant Asset Management Ltd. | |
| YP Holdings LLC (Florida) | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
| Immuni-T, Inc. | |
Jantibody LLC
Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a private company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | Health Technology |
- Stock Market
- Insiders
- Michael Yurkowsky
